Quality of Life, Depression, and Anxiety Among Hepatitis B Patients

Basit Öğe Kaydı
dc.contributor.authorKeskin, Gulseren
dc.contributor.authorBabacan Gümüş, Aysun
dc.contributor.authorOrgun, Fatma
dc.date.accessioned2025-01-27T20:39:12Z
dc.date.available2025-01-27T20:39:12Z
dc.date.issued2013
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractThis descriptive cross-sectional study was designed to determine the depression and anxiety levels, and their effects, on quality of life of patients with chronic Hepatitis B. Chronic infection with Hepatitis B virus has a profound effect on health-related quality of life. Medications, including interferon, that are commonly used to treat chronic viral Hepatitis B may cause depression as an adverse effect. However, little is known about the impact of depression and anxiety on quality of life in patients with Hepatitis B. A total of 96 patients aged between 15 and 61 years were included in the study. Slightly more than half of them (52%) were female. Three scales-the Beck Depression Inventory, Beck Anxiety Scale, and Short Form of the World Health Organization Quality of Life Questionnaire (WHOQOL-BREF)-were used in the study. The scores obtained from the BDS in 91.7% of the patients were above the cutoff value of 17. Moreover, 80 patients received interferon. There was a negative correlation between the physical, environmental, and cultural areas on the Beck Anxiety Scale and WHOQOL-BREF (Turkish) (p <.05). A high level of depressive symptoms was established in this study, and the physical, environmental, and cultural aspects of quality of life were determined to increase as the anxiety level increased.
dc.identifier.doi10.1097/SGA.0b013e3182a788cc
dc.identifier.endpage356
dc.identifier.issn1042-895X
dc.identifier.issn1538-9766
dc.identifier.issue5
dc.identifier.pmid24084133
dc.identifier.scopus2-s2.0-84885209321
dc.identifier.scopusqualityQ3
dc.identifier.startpage346
dc.identifier.urihttps://doi.org/10.1097/SGA.0b013e3182a788cc
dc.identifier.urihttps://hdl.handle.net/20.500.12428/23891
dc.identifier.volume36
dc.identifier.wosWOS:000330364300005
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofGastroenterology Nursing
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectInterferon-Alpha
dc.subjectInventory
dc.subjectState
dc.subjectImpact
dc.titleQuality of Life, Depression, and Anxiety Among Hepatitis B Patients
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu